Alexander B Olawaiye MD
Gynecologic Oncology
Associate Professor, Ob/Gyn & Reproductive Science, University of Pittsburgh School of Medicine
Join to View Full Profile
300 Halket St# Magee-WoPittsburgh, PA 15213
Phone+1 412-641-6665
Fax+1 412-641-5417
Dr. Olawaiye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Gynecologic Oncology, 2005 - 2008
University at BuffaloResidency, Obstetrics and Gynecology, 2001 - 2005
University of IbadanClass of 1991
Certifications & Licensure
PA State Medical License 2008 - 2026
MA State Medical License 2005 - 2016
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2008 Dec 01
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2010 Sep 01
- Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2014 Jul 21
Publications & Presentations
PubMed
- All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.Austin Hicks, Lauren Borho, Esther Elishaev, Jessica Berger, Michelle Boisen
Gynecologic Oncology. 2025-03-05 - Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.Alicia F C Okines, Giuseppe Curigliano, Nobumasa Mizuno, Do-Youn Oh, Andree Rorive
Nature Medicine. 2025-03-01 - Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.Stéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, William A Cliby, Mitchell I Edelson
Journal of Clinical Oncology. 2025-03-01
Journal Articles
- Survival Advantage Associated with Multimodal Therapy in Women with Node‐Positive (Stage‐IIIC) Uterine Papillary Serous Carcinoma: A National Cancer Database StudyJ F Lin, K Muniz, P Gehrig, R P Edwards, A B Olawaiye, S Beriwal, P Sukumvanich, J L Kelley, BJOG: An International Journal of Obstetrics & Gynaecology
Press Mentions
Experimental Women's Cancer Drug Boosts Survival Rates in Notable StudyApril 1st, 2025- Presidential Matters: Amanda Nickles Fader, MDFebruary 10th, 2025
- Cervical Cancer in Women 65+ Often Deadly: So Why Not Screen?January 19th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
